Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2023
Archives
Beyond amyloid: What’s next for Alzheimers disease therapeutics?
Bradlee Heckmann, PhD, from USF Health Neuroscience Institute, Byrd Alzheimer’s Center & Asha Therapeutics, in this discussion goes beyond amyloid, asking what’s next for Alzheimer’s Disease therapeutics.
Precision medicine: Sensorineural hearing loss treatment
Aarno Dietz, Professor of Otorhinolaryngology at Kuopio University Hospital, turns the spotlight on hospital precision medicine, focusing on the treatment of sensorineural hearing loss.
Visualizing the anti-inflammatory cannabinoid Type-2 receptor
Medicinal chemists describe how small molecule probes allow for the detection of CB2R, and thereby enable the discovery of novel anti-inflammatory treatments.
Solutions for healthy ageing: how technology can make a difference
Professor Alex Mihailidis, Scientific Director and CEO of AGE-WELL Network of Centres of Excellence, looks to improve wellbeing and healthy ageing in older people through innovative technology.
Ensuring healthier pets through improved nutrient precision in pet foods
Improved nutrient precision in pet foods is critical to pets, people & planet; Dennis E. Jewell, PhD from Kansas State University & Matthew I. Jackson, PhD from Hill’s Pet Nutrition, explain.
RR-TB treatments, testing bedaquiline and injectable kanamycin
Here, Professor Andre Nunn from Medical Research Council Clinical Trials Unit at UCL, explores tuberculosis with a focus on RR-TB treatments (rifampicin-resistant) and their drug combinations.
Psychedelic therapies are returning to psychiatry
Professor Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, looks to psychedelic therapies outside the pharmaceutical industry to aid mental illness.
PopART: Universal testing and treatment to stop HIV spread
Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.
Updating services for people with younger onset dementia and their caregivers
Researchers from the Jockey Club Centre for Positive Ageing analyse the services available for people with younger onset dementia, looking to improve the lives of those affected and their carers.
FMRI neurofeedback: Novel interventions for depression
Kymberly Young, an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine, discusses neurofeedback as a novel non-invasive intervention for depression.
Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients
Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
Workers at risk: How do traumatic jobs affect essential workers?
R. Nicholas Carleton and Gregory S Anderson analyse the workplace stressors and risks of public safety personnel and front-line healthcare workers.
Cool Esthesia airway hygiene: Stop stuffiness, cough and clear phlegm
Cryosim is a molecule that produces sensations of coolness but does not affect tissue temperatures. It can be delivered as a liquid to the surfaces of the nasal cavity and throat with an immediate cooling effect.
Allergic asthma and the legacy of structural racism on the African American urban communities
Allergic asthma is a chronic inflammatory disease characterized by bronchial hyperactivity, disproportionately affecting African Americans.
Great leaps in multiple sclerosis treatment but the holy grail is still ahead
CEO of MS Australia Rohan Greenland highlights the breakthroughs in treating attacks on the brain and spinal cord in multiple sclerosis (MS). But his sights are set firmly on the great unmet needs: to repair damaged nerves, reverse disability, and ultimately, prevent MS.
The WATCH project: Tanycytes in health and disease
The WATCH project aims to elucidate how tanycytes mediate physiological processes by acting as gatekeepers between the brain and body, how their dysfunction is involved in various disorders and age-related impairments, and what can be done to prevent or correct these.
Innovative approaches to cancer treatments oncological engineering
Prof Richard M Hall, School of Mechanical Engineering, University of Leeds, explores how oncological engineering is paving the way for new and innovative cancer treatments.
Challenges bringing CB₂R medicine to bedside
Drug hunters explain how to overcome pitfalls on the way to CB2R medicine and therapeutics.
A new approach to older people’s end of life care: Living and dying well
Remodelling palliative and end of life care requires different ways of working, different partnerships and a sharing of power.
The euPOLIS vision: Improving well-being with nature-based solutions
The adverse effects of urbanization have taken a toll on people’s mental and physical health, here’s how co-design and nature-based solutions can lead the way in mitigating these risks.
